Skip to main content

Michael Dewall, DO

Case Report
02/04/2025
This case report demonstrates the effectiveness of rituximab as a first-line and maintenance treatment for this rare antineutrophil cytoplasmic antibody-associated vasculitis.
This case report demonstrates the effectiveness of rituximab as a first-line and maintenance treatment for this rare antineutrophil cytoplasmic antibody-associated vasculitis.
This case report demonstrates...
02/04/2025
The Dermatologist